Today’s Solutions: November 28, 2023

We have good news for bread lovers who suffer from Celiac disease or gluten intolerance. This week, Northwestern University completed a successful trial to alleviate inflammatory responses to gluten in individuals with allergies, using nanoparticle technology.

This nanoparticle technology envelops the problematic allergen with a substance which the body recognizes as harmless debris, allowing macrophages, also known as the vacuum cleaner cells, to remove it without triggering an allergic response. 

A Phase 2 trial of 34 individuals is the first evidence of efficacy in humans, but the technology has been granted a Fast Track by the FDA, so it will hopefully be approved and more widely available soon. If approved, this technology could potentially be used to treat a wide variety of allergies and autoimmune conditions. 

Solutions News Source Print this article
More of Today's Solutions

The EU makes historic decision to stop plastic waste exports to poor countries

The European Union took an important step toward reducing plastic pollution by agreeing to stop exporting waste plastic to non-OECD countries. This landmark decision, ...

Read More

Recovering from family gatherings: your essential guide to recharge and reset

A flurry of family visits might leave you reeling and wondering, "What just happened?" The intensity of spending time with family may be emotionally ...

Read More

How your body and mind can benefit from dark chocolate

For more than 3,000 years, chocolate has been used for its healing properties. Flash forward to today, and scientists are finding scientific evidence for ...

Read More

World’s first hydrogen-powered cargo vessel to set sail in Paris this year

In a world's first, a commercial hydrogen-powered cargo vessel will make its maiden voyage later this year. Developed by French shipowner Compagnie Fluvial Transport ...

Read More